[
    [
        {
            "time": "",
            "original_text": "贵州百灵（002424.SZ）：近期收到药明康德关于“替芬泰”的实验研究报告",
            "features": {
                "keywords": [
                    "贵州百灵",
                    "药明康德",
                    "替芬泰",
                    "实验研究报告"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "贵州百灵（002424.SZ）：近期收到药明康德关于“替芬泰”的实验研究报告",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "近期市场流动性变化情况",
            "features": {
                "keywords": [
                    "市场流动性",
                    "变化情况"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "近期市场流动性变化情况",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 1,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "中泰国际2022年医药行业投资策略：刚需稳健，坚守成长",
            "features": {
                "keywords": [
                    "中泰国际",
                    "医药行业",
                    "投资策略",
                    "刚需稳健",
                    "坚守成长"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "中泰国际2022年医药行业投资策略：刚需稳健，坚守成长",
                "Correlation": 4,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "北水连续第13日加仓腾讯，今日再度狂买近15亿港元；南水连续4日甩卖药明康德",
            "features": {
                "keywords": [
                    "北水",
                    "腾讯",
                    "加仓",
                    "南水",
                    "甩卖",
                    "药明康德"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "科技",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "北水连续第13日加仓腾讯，今日再度狂买近15亿港元；南水连续4日甩卖药明康德",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "北向资金净卖出近10亿元 药明康德遭减持8.85亿元 减持股份",
            "features": {
                "keywords": [
                    "北向资金",
                    "净卖出",
                    "药明康德",
                    "减持"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "北向资金净卖出近10亿元 药明康德遭减持8.85亿元 减持股份",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "港股异动 | 药明康德(02359)下挫8%领跌CXO板块 需求端担忧成抛售主因之一",
            "features": {
                "keywords": [
                    "港股",
                    "药明康德",
                    "下挫",
                    "CXO板块",
                    "需求端担忧",
                    "抛售"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "港股异动 | 药明康德(02359)下挫8%领跌CXO板块 需求端担忧成抛售主因之一",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 9,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "A股收盘综述：创业板指跌近3%，新能源股大步回撤",
            "features": {
                "keywords": [
                    "A股",
                    "收盘",
                    "创业板指",
                    "新能源股",
                    "回撤"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "新能源"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "A股收盘综述：创业板指跌近3%，新能源股大步回撤",
                "Correlation": 2,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 1,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医药行业一周观察：“实体清单”落地 关注CXO 上下游高景气标的",
            "features": {
                "keywords": [
                    "医药行业",
                    "实体清单",
                    "CXO",
                    "上下游",
                    "高景气"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药行业一周观察：“实体清单”落地 关注CXO 上下游高景气标的",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]